Legal & General Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.52M Buy
219,920
+45,576
+26% +$729K ﹤0.01% 1709
2025
Q1
$3.39M Buy
174,344
+14,121
+9% +$274K ﹤0.01% 1707
2024
Q4
$3.53M Buy
160,223
+48,047
+43% +$1.06M ﹤0.01% 1745
2024
Q3
$1.89M Buy
112,176
+6,967
+7% +$117K ﹤0.01% 2000
2024
Q2
$1.26M Buy
105,209
+53,626
+104% +$641K ﹤0.01% 2119
2024
Q1
$572K Buy
51,583
+6,055
+13% +$67.1K ﹤0.01% 2379
2023
Q4
$394K Buy
45,528
+2,100
+5% +$18.2K ﹤0.01% 2541
2023
Q3
$332K Buy
43,428
+20,228
+87% +$155K ﹤0.01% 2591
2023
Q2
$167K Buy
23,200
+16,603
+252% +$120K ﹤0.01% 2771
2023
Q1
$40.2K Hold
6,597
﹤0.01% 2915
2022
Q4
$28.8K Buy
6,597
+1,364
+26% +$5.95K ﹤0.01% 3060
2022
Q3
$21K Hold
5,233
﹤0.01% 3189
2022
Q2
$27K Hold
5,233
﹤0.01% 3136
2022
Q1
$33K Buy
+5,233
New +$33K ﹤0.01% 3095